See it in color
Our video library features medical experts and community members who help grow your understanding of the impact of breast cancer on every aspect of your life.
Your go-to source for the medical news and practical information that impacts your care.
07/13/23 | BY: Wendy Univer
Studies show some people don't start and many quit HTs that reduce risk of recurrence, due to intolerable side effects; communication with your provider is key to making informed treatment decisions.
Reasons young women stop taking tamoxifen vary over time
Looking at a little understood yet common phenomenon—women discontinuing tamoxifen therapy early—French researchers found several factors caused women to interrupt treatment. These factors varied, depending upon when the women stopped therapy.
Everolimus gains FDA approval for metastatic breast cancer
Postmenopausal women with metastatic, hormone receptor-positive breast cancer may now be treated with everolimus (Afinitor) in combination with exemestane (Aromasin), following FDA’s recent approval of the tablet medicine.
Infants exposed to chemotherapy during pregnancy develop normally
A recent study of the long-term outcomes, or effects, for children exposed to chemotherapy during pregnancy has shown that most have normal heart, brain and cognitive functions despite exposure to treatment.
Your source for easy-to-digest medical news and life management tools.
Get medical news from the San Antonio Breast Cancer Symposium and ASCO. Our curated stories guide you through the most important issues facing the breast cancer community – and help you understand how they impact your care and your life.
Have a question? Get in touch with us.
Breast cancer news is designed for educational and informational purposes only. For answers to specific questions or concerns, please consult your health care providers. Our content is not intended in any way to substitute for professional counseling or medical advice.